Efficacy of intravascular ultrasound in femoropopliteal stenting for peripheral artery disease with TASC II class a to C lesions

Journal of Endovascular Therapy

Volumn 21, Issue 4, 2014, Pages 485-492

  Iida, Osamu ^a   Takahara, Mitsuyoshi ^b   Soga, Yoshimitsu ^c   Suzuki, Kenji ^d   Hirano, Keisuke ^e   Kawasaki, Daizo ^f   Shintani, Yoshiaki ^g   Suematsu, Nobuhiro ^h   Yamaoka, Terutoshi ⁱ   Nanto, Shinsuke ^b   Uematsu, Masaaki ^a  

^a KANSAI ROSAI HOSPITAL   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KOKURA MEMORIAL HOSPITAL   (Japan)

^d Sendai Kosei Hospital   (Japan)

^e SAISEIKAI YOKOHAMASHI TOBU HOSPITAL   (Japan)

^f OSAKA UNIVERSITY   (Japan)

^g Shinkoga Hospital   (Japan)

^h FUKUOKA RED CROSS HOSPITAL   (Japan)

ⁱ MATSUYAMA RED CROSS HOSPITAL   (Japan)

Author keywords

Balloon angioplasty; Femoropopliteal segment; Intravascular ultrasound; Occlusion; Patency; Peripheral artery disease; Popliteal artery; Restenosis; Stenosis; Stent; Superficial femoral artery

Indexed keywords

ALLOY; NITINOL;

ADVERSE EFFECTS; AGED; CLINICAL TRIAL; DEVICES; DISEASE FREE SURVIVAL; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; ENDOVASCULAR SURGERY; FACTUAL DATABASE; FEMALE; FEMORAL ARTERY; HUMAN; JAPAN; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODEL; PROSTHESIS; RETROSPECTIVE STUDY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STENOSIS, OCCLUSION AND OBSTRUCTION; STENT; TIME; TREATMENT OUTCOME; VASCULAR PATENCY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALLOYS; CONSTRICTION, PATHOLOGIC; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; ENDOVASCULAR PROCEDURES; FEMALE; FEMORAL ARTERY; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STENTS; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL; VASCULAR PATENCY;

EID: 84905856463     PISSN: 15266028     EISSN: 15451550     Source Type: Journal    
DOI: 10.1583/14-4721R.1     Document Type: Article

References (12)

1. Tendera M, Aboyans V, Bartelink ML, et al; ESC Committee for Practice Guidelines. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2011;32:2851-2906.
2. Schillinger M, Sabeti S, Loewe C, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006;354:1879-1888. (Pubitemid 43872689)
3. Laird JR, Katzen BT, Scheinert D, et al; RESILIENT Investigators. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv. 2010;3:267-276.
4. Lammer J, Zeller T, Hausegger KA, et al. Heparin-bonded covered stents versus baremetal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease). J Am Coll Cardiol. 2013;62:1320-1327.
5. Soga Y, Iida O, Hirano K, et al. Utility of new classification based on clinical and lesional factors after self-expandable nitinol stenting in the superficial femoral artery. J Vasc Surg. 2011;54:1058-1066.
6. Soga Y, Iida O, Hirano K, et al. Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent. J Vasc Surg. 2010;52:608-615.
7. Schulte KL, Kralj I, Gissler HM, et al. MISAGO 2: one-year outcomes after implantation of the Misago self-expanding nitinol stent in the superficial femoral and popliteal arteries of 744 patients. J Endovasc Ther. 2012;19:774-784.
8. Roy P, Steinberg DH, Sushinsky SJ, et al. The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents. Eur Heart J. 2008;29:1851-1857
9. Fitzgerald PJ, Oshima A, Hayase M, et al. Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) study. Circulation. 2000;102:523-530. (Pubitemid 30639970)
10. Conte MS, Geraghty PJ, Bradbury AW, et al. Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia. J Vasc Surg. 2009;50:1462-1473.
11. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41-55.
12. Austin PC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat. 2011;10:150-161.